medicare coverage for glp 1 drugs to cover GLP-1 weight loss $50/month Some insurers are dropping GLP-1

Cost has been one of the biggest barriers to treatment, with many patients unable to access these medications because insurance coverage is limited and out-of-pocket prices remain high

These data collectively suggest that Pdx1 requires interaction with other transcription factors to inhibit Gcg expression

Figure 1 Statements Author contributions All authors listed have made a substantial, direct, and intellectual contribution to the work and approved it for publication

Susan Yanovski, a physician and nutrition specialist at the National Institute of Diabetes and Digestive and Kidney Diseases, noted: "It's the first time doctors have had obesity drugs that work so well, approaching weight-loss levels previously seen only with bariatric surgery." For decades, bariatric surgery was the only treatment that consistently produced double-digit weight loss percentages